Kutatási jelek – Signal Engine

Pelvic MRI in Endometrial Cancer Staging: A Retrospective Evaluation of the Impact of FIGO 2023 — Endometrial cancer
AL398, a Novel NSUN6 Inhibitor, Attenuates Epithelial‑Mesenchymal Transition and Metastasis in Endometrial Cancer by Abrogating m5C‑Dependent Stabilization of Snail mRNA — Endometrial cancer
Radiological Loco‑Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature — Cholangiocarcinoma
Advance Healthcare Materials — Cholangiocarcinoma
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study — Cholangiocarcinoma
Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF / MEK Inhibitors: A Case Report — Cholangiocarcinoma
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma. — Cholangiocarcinoma
E2A selectively regulates TGF‑β‑induced apoptosis in KRAS‑mutant non‑small cell lung cancer — NSCLC
KRAS-mutated Non‑Small Cell Lung Cancer : The Cancer Journal — NSCLC
Scientists uncover promising new way to treat an ‘undruggable’ type of lung cancer — NSCLC
What's Coming Up on the Lung Cancer Treatment Horizon? — NSCLC
HHS lung cancer patient thrives thanks to research trial - Hamilton Health Sciences — NSCLC
Markey home to two breakthrough therapeutic cancer vaccine trials — SCLC
UT MD Anderson Shares Latest Research Breakthroughs — Pancreatic cancer
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma — Hepatocellular carcinoma
How Traditional Chinese Medicine Works: Biological Mechanisms and Clinical Evidence for Hepatocellular Carcinoma Treatment — Hepatocellular carcinoma
Development of a PNI-Based Prognostic Model for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib-Based Triple Therapy — Hepatocellular carcinoma
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease — Hepatocellular carcinoma
Lymphocyte‑Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis — Hepatocellular carcinoma
MRI of Hepatocellular Carcinoma: Cross-regional Perspectives on Trends and Opportunities — Hepatocellular carcinoma